GF Fund Management CO. LTD. Invests $12.14 Million in UnitedHealth Group Incorporated (NYSE:UNH)

GF Fund Management CO. LTD. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 23,992 shares of the healthcare conglomerate's stock, valued at approximately $12,137,000.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on UNH. Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. HSBC restated a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Finally, Morgan Stanley reduced their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $441.87.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Trading Up 1.5%

Shares of UNH traded up $4.54 during midday trading on Wednesday, reaching $299.54. The company had a trading volume of 10,667,182 shares, compared to its average volume of 10,607,845. The firm has a 50 day simple moving average of $443.90 and a 200-day simple moving average of $500.04. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $271.73 billion, a PE ratio of 19.33, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.